Works by Grubmüller, Bernhard

Results: 28

Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study.

Published in:

Clinical Epigenetics, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13148-025-01811-5

By:

Kluge, Kilian;
Lotz, Vincent;
Einspieler, Holger;
Haberl, David;
Spielvogel, Clemens;
Amereller, Dominik;
Kramer, Gero;
Grubmüller, Bernhard;
Shariat, Shahrokh;
Haug, Alexander;
Hacker, Marcus;
Kenner, Lukas;
Egger, Gerda

Publication type:

Article

Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.

Published in:

Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-021-01445-0

By:

Dillinger, Thomas;
Sheibani-Tezerji, Raheleh;
Pulverer, Walter;
Stelzer, Ines;
Hassler, Melanie R.;
Scheibelreiter, Janine;
Pérez Malla, Carlos Uziel;
Kuroll, Madeleine;
Domazet, Sandra;
Redl, Elisa;
Ely, Sarah;
Brezina, Stefanie;
Tiefenbacher, Andreas;
Rebhan, Katharina;
Hübner, Nicolai;
Grubmüller, Bernhard;
Mitterhauser, Markus;
Hacker, Marcus;
Weinhaeusel, Andreas;
Simon, Judit

Publication type:

Article

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups.

Published in:

Asia Oceania Journal of Nuclear Medicine & Biology, 2019, v. 7, n. 2, p. 149, doi. 10.22038/AOJNMB.2019.35768.1242

By:

Sevcenco, Sabina;
Grubmüller, Bernhard;
Sonneck-Koenne, Charlotte;
Ahmadi, Yasaman;
Knoll, Peter;
Floth, Andreas;
Pokieser, Wolfgang;
Zandieh, Shahin;
Klingler, Hans Christoph;
Shariat, Sharokh;
Mirzaei, Siroos

Publication type:

Article

The prognostic impact of tumour NSD2 expression in advanced prostate cancer.

Published in:

Biomarkers, 2020, v. 25, n. 3, p. 268, doi. 10.1080/1354750X.2020.1734861

By:

Stangl-Kremser, Judith;
Lemberger, Ursula;
Hassler, Melanie R.;
Garstka, Nathalie;
Grubmüller, Bernhard;
Haitel, Andrea;
Enikeev, Dmitry V.;
Glybochko, Petr V.;
Kramer, Gero;
Susani, Martin;
Shariat, Shahrokh F.

Publication type:

Article

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI.

Published in:

Insights into Imaging, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13244-024-01876-5

By:

Spielvogel, Clemens P.;
Ning, Jing;
Kluge, Kilian;
Haberl, David;
Wasinger, Gabriel;
Yu, Josef;
Einspieler, Holger;
Papp, Laszlo;
Grubmüller, Bernhard;
Shariat, Shahrokh F.;
Baltzer, Pascal A. T.;
Clauser, Paola;
Hartenbach, Markus;
Kenner, Lukas;
Hacker, Marcus;
Haug, Alexander R.;
Rasul, Sazan

Publication type:

Article

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.

Published in:

World Journal of Urology, 2017, v. 35, n. 1, p. 113, doi. 10.1007/s00345-016-1835-1

By:

Favaretto, Ricardo;
Bahadori, Atessa;
Mathieu, Romain;
Haitel, Andrea;
Grubmüller, Bernhard;
Margulis, Vitaly;
Karam, Jose;
Rouprêt, Morgan;
Seitz, Christian;
Karakiewicz, Pierre;
Cunha, Isabela;
Zequi, Stenio;
Wood, Christopher;
Weizer, Alon;
Raman, Jay;
Remzi, Mesut;
Rioux-Leclercq, Nathalie;
Jacquet-Kammerer, Solene;
Bensalah, Karim;
Lotan, Yair

Publication type:

Article

Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2833, doi. 10.1007/s00259-024-06698-7

By:

Kluge, Kilian;
Einspieler, Holger;
Haberl, David;
Spielvogel, Clemens;
Amereller, Dominik;
Egger, Gerda;
Kramer, Gero;
Grubmüller, Bernhard;
Shariat, Shahrokh;
Hacker, Marcus;
Kenner, Lukas;
Haug, Alexander

Publication type:

Article

Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective–Prospective [68Ga]Ga-PSMA-11 PET/CT Study.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 63, doi. 10.2967/jnumed.123.266158

By:

Kluge, Kilian;
Einspieler, Holger;
Haberl, David;
Spielvogel, Clemens;
Stoiber, Stefan;
Vraka, Chrysoula;
Papp, Laszlo;
Wunsch, Sabine;
Egger, Gerda;
Kramer, Gero;
Grubmüller, Bernhard;
Shariat, Shahrokh;
Hacker, Marcus;
Kenner, Lukas;
Haug, Alexander

Publication type:

Article

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1730, doi. 10.2967/jnumed.123.265980

By:

Kluge, Kilian;
Haberl, David;
Einspieler, Holger;
Rasul, Sazan;
Gutschmayer, Sebastian;
Kenner, Lukas;
Kramer, Gero;
Grubmüller, Bernhard;
Shariat, Shahrokh;
Haug, Alexander;
Hacker, Marcus

Publication type:

Article

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 863, doi. 10.2967/jnumed.122.264981

By:

Jalali, Valentin al;
Wasinger, Gabriel;
Rasul, Sazan;
Grubmüller, Bernhard;
Wulkersdorfer, Beatrix;
Balber, Theresa;
Mitterhauser, Markus;
Simon, Judit;
Hacker, Marcus;
Shariat, Shahrokh;
Egger, Gerda;
Zeitlinger, Markus

Publication type:

Article

Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1650, doi. 10.1007/s00259-020-05082-5

By:

Rasul, Sazan;
Hartenbach, Markus;
Wollenweber, Tim;
Kretschmer-Chott, Elisabeth;
Grubmüller, Bernhard;
Kramer, Gero;
Shariat, Shahrokh;
Wadsak, Wolfgang;
Mitterhauser, Markus;
Pichler, Verena;
Vraka, Chrysoula;
Hacker, Marcus;
Haug, Alexander R.

Publication type:

Article

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 713, doi. 10.1007/s00259-019-04584-1

By:

Rasul, Sazan;
Hacker, Marcus;
Kretschmer-Chott, Elisabeth;
Leisser, Asha;
Grubmüller, Bernhard;
Kramer, Gero;
Shariat, Shahrokh;
Wadsak, Wolfgang;
Mitterhauser, Markus;
Hartenbach, Markus;
Haug, Alexander R.

Publication type:

Article

Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 10, p. 2169, doi. 10.1007/s00259-019-04361-0

By:

Abufaraj, Mohammad;
Grubmüller, Bernhard;
Zeitlinger, Markus;
Kramer, Gero;
Seitz, Christian;
Haitel, Andrea;
Baltzer, Pascal;
Hacker, Marcus;
Wadsak, Wolfgang;
Pfaff, Sarah;
Wiatr, Tomasz;
Mitterhauser, Markus;
Shariat, Shahrokh F.;
Hartenbach, Markus

Publication type:

Article

Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 5, p. 1063, doi. 10.1007/s00259-018-4236-4

By:

Kramer, Gero;
D'Andrea, David;
Grubmüller, Bernhard;
Shariat, Shahrokh F.;
Hartenbach, Markus;
Baltzer, Pascal;
Senn, Daniela;
Eidherr, Harald;
Haug, Alexander R.;
Pfaff, Sarah;
Hacker, Marcus;
Mitterhauser, Markus;
Wadsak, Wolfgang;
Grubmüller, Karl Hermann

Publication type:

Article

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.

Published in:

BJUI Compass, 2023, v. 4, n. 1, p. 123, doi. 10.1002/bco2.182

By:

Bravi, Carlo A.;
Heidenreich, Axel;
Fossati, Nicola;
Gandaglia, Giorgio;
Suardi, Nazareno;
Mazzone, Elio;
Stabile, Armando;
Cucchiara, Vito;
Osmonov, Daniar;
Juenemann, Klaus‐Peter;
Karnes, R. Jeffrey;
Kretschmer, Alexander;
Buchner, Alexander;
Stief, Christian;
Hiester, Andreas;
Albers, Peter;
Devos, Gaëtan;
Joniau, Steven;
Van Poppel, Hendrik;
Grubmüller, Bernhard

Publication type:

Article

Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [ 68 Ga]Ga-PSMA-11-PET Examinations.

Published in:

Cancers, 2024, v. 16, n. 8, p. 1514, doi. 10.3390/cancers16081514

By:

Einspieler, Holger;
Kluge, Kilian;
Haberl, David;
Schatz, Katrin;
Nics, Lukas;
Schmitl, Stefan;
Geist, Barbara Katharina;
Spielvogel, Clemens P.;
Grubmüller, Bernhard;
Baltzer, Pascal A. T.;
Kramer, Gero;
Shariat, Shahrokh F.;
Hacker, Marcus;
Rasul, Sazan

Publication type:

Article

Response and Toxicity to the Second Course of 3 Cycles of 177 Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.

Published in:

Cancers, 2021, v. 13, n. 10, p. 2489, doi. 10.3390/cancers13102489

By:

Rasul, Sazan;
Wollenweber, Tim;
Zisser, Lucia;
Kretschmer-Chott, Elisabeth;
Grubmüller, Bernhard;
Kramer, Gero;
Shariat, Shahrokh F.;
Eidherr, Harald;
Mitterhauser, Markus;
Vraka, Chrysoula;
Langsteger, Werner;
Hacker, Marcus;
Haug, Alexander R.;
López, José I.

Publication type:

Article

MUW researcher of the month.

Published in:

Wiener Klinische Wochenschrift, 2018, v. 130, n. 23/24, p. 740, doi. 10.1007/s00508-018-1427-8

By:

Grubmüller, Bernhard

Publication type:

Article

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?

Published in:

2021

By:

Huebner, Nicolai Alexander;
Korn, Stephan;
Resch, Irene;
Grubmüller, Bernhard;
Gross, Tobias;
Gale, Robert;
Kramer, Gero;
Poetsch, Nina;
Clauser, Paola;
Haitel, Andrea;
Fajkovic, Harun;
Shariat, Shahrokh F.;
Baltzer, Pascal A.

Publication type:

journal article

Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.

Published in:

Scandinavian Journal of Urology, 2020, v. 54, n. 1, p. 52, doi. 10.1080/21681805.2019.1711160

By:

D'Andrea, David;
Soria, Francesco;
Zehetmayer, Sonja;
Stangl-Kremser, Judith;
Grubmüller, Bernhard;
Abufaraj, Mohammad;
Gust, Kilian;
Kimura, Shoji;
Babjuk, Marko;
Goldner, Gregor M.;
Shariat, Shahrokh F.

Publication type:

Article

Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy.

Published in:

Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1231, doi. 10.3390/jpm11111231

By:

Rajwa, Pawel;
Huebner, Nicolai A.;
Hostermann, Dadjar I.;
Grossmann, Nico C.;
Schuettfort, Victor M.;
Korn, Stephan;
Quhal, Fahad;
König, Frederik;
Mostafaei, Hadi;
Laukhtina, Ekaterina;
Mori, Keiichiro;
Motlagh, Reza Sari;
Yanagisawa, Takafumi;
Aydh, Abdulmajeed;
Bryniarski, Piotr;
Pradere, Benjamin;
Paradysz, Andrzej;
Baltzer, Pascal A.;
Grubmüller, Bernhard;
Shariat, Shahrokh F.

Publication type:

Article

Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer.

Published in:

Prostate, 2020, v. 80, n. 1, p. 74, doi. 10.1002/pros.23919

By:

Grubmüller, Bernhard;
Rasul, Sazan;
Baltzer, Pascal;
Fajkovic, Harun;
D'Andrea, David;
Berndl, Florian;
Maj‐Hes, Agnes;
Grubmüller, Karl Hermann;
Mitterhauser, Markus;
Wadsak, Wolfgang;
Pfaff, Sarah;
Shariat, Shahrokh F.;
Hacker, Marcus;
Kramer, Gero;
Hartenbach, Markus

Publication type:

Article

Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy.

Published in:

Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 719, doi. 10.1007/s00066-022-01909-2

By:

Moll, Matthias;
D'Andrea, David;
Zaharie, Alexandru;
Grubmüller, Bernhard;
Paschen, Christopher;
Zehetmayer, Sonja;
Shariat, Shahrokh F.;
Widder, Joachim;
Goldner, Gregor

Publication type:

Article

Ein Clip zu viel.

Published in:

Die Urologie, 2023, v. 62, n. 4, p. 389, doi. 10.1007/s00120-022-02013-0

By:

Felsner, Marlene;
Grubmüller, Bernhard

Publication type:

Article

A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.

Published in:

Theranostics, 2024, v. 14, n. 12, p. 4570, doi. 10.7150/thno.96921

By:

Ning, Jing;
Spielvogel, Clemens P.;
Haberl, David;
Trachtova, Karolina;
Stoiber, Stefan;
Rasul, Sazan;
Bystry, Vojtech;
Wasinger, Gabriel;
Baltzer, Pascal;
Gurnhofer, Elisabeth;
Timelthaler, Gerald;
Schlederer, Michaela;
Papp, Laszlo;
Schachner, Helga;
Helbich, Thomas;
Hartenbach, Markus;
Grubmüller, Bernhard;
Shariat, Shahrokh F;
Hacker, Marcus;
Haug, Alexander

Publication type:

Article

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer.

Published in:

Current Oncology, 2023, v. 30, n. 2, p. 1683, doi. 10.3390/curroncol30020129

By:

Grubmüller, Bernhard;
Huebner, Nicolai A.;
Rasul, Sazan;
Clauser, Paola;
Pötsch, Nina;
Grubmüller, Karl Hermann;
Hacker, Marcus;
Hartenbach, Sabrina;
Shariat, Shahrokh F.;
Hartenbach, Markus;
Baltzer, Pascal

Publication type:

Article

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.

Published in:

Current Oncology, 2021, v. 28, n. 5, p. 3692, doi. 10.3390/curroncol28050315

By:

Wollenweber, Tim;
Zisser, Lucia;
Kretschmer-Chott, Elisabeth;
Weber, Michael;
Grubmüller, Bernhard;
Kramer, Gero;
Shariat, Shahrokh F.;
Mitterhauser, Markus;
Schmitl, Stefan;
Vraka, Chrysoula;
Haug, Alexander R.;
Hacker, Marcus;
Hartenbach, Markus;
Rasul, Sazan

Publication type:

Article

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response.

Published in:

Current Oncology, 2021, v. 28, n. 4, p. 2881, doi. 10.3390/curroncol28040252

By:

Grubmüller, Bernhard;
Jahrreiss, Victoria;
Brönimann, Stephan;
Quhal, Fahad;
Keiichiro Mori;
Heidenreich, Axel;
Briganti, Alberto;
Tilki, Derya;
Shariat, Shahrokh F.

Publication type:

Article

Works by Grubmüller, Bernhard

Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study.

Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups.

The prognostic impact of tumour NSD2 expression in advanced prostate cancer.

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRI.

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.

Comparison of discovery rates and prognostic utility of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study.

Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective–Prospective [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT Study.

Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.

Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.

Prospective evaluation of the performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.

Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.

Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [ 68 Ga]Ga-PSMA-11-PET Examinations.

Response and Toxicity to the Second Course of 3 Cycles of 177 Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.

MUW researcher of the month.

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?

Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.

Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy.

Response assessment using [<sup>68</sup>Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer.

Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy.

Ein Clip zu viel.

A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer.

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response.